Objective: The breast may be affected by reactive and lymphoproliferative processes such as primary (PBL) or secondary (SBL) lymphoma, reactive intramammary lymph nodes and sclerosing lobulitis; imaging may be not specific and surgical treatment not indicated. We report an experience with fine-needle cytology (FNAC) combined with flow cytometry (FC) and immunocytochemistry (ICC) in the diagnosis of these processes. Study Design: Thirty-seven cases comprising intramammary lymph nodes (n = 15), sclerosing lobulitis (n = 2), PBL (n = 11) and SBL (n = 9) are reported. FNAC was used to prepare traditional smears, conventional ICC or FC. Cytological diagnoses were compared to the imaging data, checked by histology or follow-up and statistically evaluated. Results: Imaging was not conclusive in most PBL, SBL, sclerosing lobulitis and some intramammary lymph nodes. FNAC combined with FC and ICC provided a definitive diagnosis of intramammary lymph node, sclerosing lobulitis, PBL and SBL in 18 cases with indication of the specific subtype in 10 cases. Statistical analysis showed 90% sensitivity, 100% specificity, 100% positive predictive value and 89% negative predictive value. Conclusions: FNAC combined with FC and ICC is a helpful procedure for the diagnosis of reactive and lymphoproliferative processes of the breast. It may prevent unnecessary biopsy and speed up therapeutic procedures.

1.
Lammie GA, Bobrow LG, Staunton MD, Levison DA, Page G, Millis RR: Sclerosing lymphocytic lobulitis of the breast: evidence for an autoimmune pathogenesis. Histopathology 1991;19:13–20.
2.
Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP: Lymphomas of the breast: primary and secondary involvement. Cancer 2002;94:6–13.
3.
Wong WW, Schild SE, Halyard MY, Schomberg PJ: Primary non-Hodgkin lymphoma of the breast: the Mayo Clinic Experience. J Surg Oncol 2002;80:19–25.
4.
Baker R, Slayden G, Jennings W: Multifocal primary breast lymphoma. South Med J 2005;98:1045–1048.
5.
Babovic N, Jelic S, Jovanovic V: Primary non-Hodgkin lymphoma of the breast. Is it possible to avoid mastectomy? J Exp Clin Cancer Res 2000;19:149–154.
6.
Mason HS, Johari V, March DE, Crisi GM: Primary breast lymphoma: radiologic and pathologic findings. Breast J 2005;11:495–496.
7.
Duncan VE, Reddy VV, Jhala NC, Chhieng DC, Jhala DN: Non-Hodgkin’s lymphoma of the breast: a review of 18 primary and secondary cases. Ann Diagn Pathol 2006;10:144–148.
8.
Jeanneret-Sozzi W, Taghian A, Epelbaum R, Poortmans P, Zwahlen D, Amsler B, Villette S, Belkacémi Y, Nguyen T, Scalliet P, Maingon P, Gutiérrez C, Gastelblum P, Krengli M, Raad RA, Ozsahin M, Mirimanoff RO: Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre rare cancer network study. BMC Cancer 2008;8:86.
9.
Sabaté JM, Gómez A, Torrubia S, Camins A, Roson N, De Las Heras P, Villalba-Nuño V: Lymphoma of the breast: clinical and radiologic features with pathologic correlation in 28 patients. Breast J 2002;8:294–304.
10.
Schmidt WA, Boudousquie AC, Vetto JT, Pommier RF, Alexander P, Thurmond A, Scanlan RM, Jones MK: Lymph nodes in the human female breast: a review of their detection and significance. Hum Pathol 2001;32:178–187.
11.
Tomaszewski JE, Brooks JS, Hicks D, Livolsi VA: Diabetic mastopathy: a distinctive clinicopathologic entity. Hum Pathol 1992;23:780–786.
12.
Ogawa T, Tsuji E, Shirakawa K, Hayashibara N, Kurabayashi R, Terada K, Kikuchi Y, Kanauchi H, Sakatani T: Primary non-Hodgkin’s lymphoma of the breast treated nonsurgically: report of three cases. Breast Cancer 2011;18:68–72.
13.
Julen O, Dellacasa I, Pelte MF, Borish B, Bouchardy C, Capanna F, Vlastos G, Dubuisson JB, Vlastos AT: Primary breast lymphomas. Rare Tumors 2009;1:e14.
14.
Singh NG, Kapila K, Dawar R, Verma K: Fine needle aspiration cytology diagnosis of lymphoproliferative disease of the breast. Acta Cytol 2003;47:739–743.
15.
Avenia N, Sanguinetti A, Cirocchi R, Bistoni G, Trastulli S, D’Ajello F, Barberini F, Cavallaro G, Rulli A, Sidoni A, Noya G, De Toma G, Sciannameo F: Primary breast lymphomas: a multicentric experience. World J Surg Oncol 2010;8:53.
16.
Nagata S, Nishimura A, Iwashita Y, Kinoshita T, Fukuzawa K, Tashiro H, Wakasugi K: Primary breast lymphoma in the right breast during treatment for left breast cancer. World J Surg Oncol 2007;5:134.
17.
Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF, Vice HM, Sheehan WW, Broughan TA: Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg 2007;245:784–789.
18.
Levine PH, Zamuco R, Yee HT: Role of fine-needle aspiration cytology in breast lymphoma. Diagn Cytopathol 2004;30:332–340.
19.
Zeppa P, Picardi M, Cozzolino I, Troncone G, Lucariello A, De Renzo A, Pane F, Rotoli B, Vetrani A, Palombini L: Fine-needle aspiration cytology in the follow-up of Hodgkin lymphoma. Diagn Cytopathol 2008;36:467–472.
20.
Layfield LJ, Glasgow BJ, Hirschcowitz S, Dodd LG: Intramammary lymph nodes: cytologic findings and implications for fine-needle aspiration cytology diagnosis of breast nodules. Diagn Cytopathol 1997;17:223–229.
21.
Venizelos ID, Tatsiou ZA, Vakalopoulou S, Mandala E, Garipidou V: Primary non-Hodgkin’s lymphoma arising in an intramammary lymph node. Leuk Lymphoma 2005;46:451–455.
22.
Zack JR, Trevisan SG, Gupta M: Primary breast lymphoma originating in a benign intramammary lymph node. AJR Am J Roentgenol 2001;177:177–178.
23.
Miralles TG, Gosalbez F, Menendez P, Manjon JA, Sampedro A: Fine needle aspiration of sclerosing lymphocytic lobulitis of the breast. A report of two cases. Acta Cytol 1998;42:1447–1450.
24.
Hugh JC, Jackson FI, Hanson J, Poppema S: Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990;66:2602–2611.
25.
Giardini R, Piccolo C, Rilke F: Primary non-Hodgkin’s lymphomas of the female breast. Cancer 1992;69:725–735.
26.
Mattia AR, Ferry JA, Harris NL: Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 1993;17:574–587.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.